Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
2.97
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.97
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT

Anixa Biosciences Cash Flow Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Net Income
-12.7M -9.93M -13.77M -13.13M
Depreciation & Amortization
37K 46K 42K 59.86K
Stock-Based Compensation
4.42M 4.42M 6M 7.5M
Other Working Capital
110K -1M 356K 174.72K
Other Non-Cash Items
380K 313K 752K -5.45K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
526K -1.06M 485K 78.55K
Operating Cash Flow
-7.33M -6.21M -6.49M -4.94M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a 6.47K
Purchase of Investments
n/a -44.41M -22.49M -16.5M
Sales Maturities Of Investments
68.05M 38.81M 11.76M 12.54M
Other Investing Acitivies
-63.77M n/a -10.73M 35.45K
Investing Cash Flow
4.28M -5.6M -10.73M -3.92M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-6K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
466K 366K 452K 439.79K
Financial Cash Flow
3.42M 366K 452K 31.57M
Net Cash Flow
356K -11.45M -16.77M 22.71M
Free Cash Flow
-7.33M -6.21M -6.49M -4.94M